Based on the lessons learned from the agpat6-deficient mice, we hypothesized that variation in the human AGPAT6 may associate with obesity, hypertriglyceridemia, insulin resistance and type 2 diabetes susceptibility. This evidence concerns the gene GPAT4 and type 2 diabetes mellitus.